Luanda De Alleluia
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Flavia Anisio
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Liziane Nunes
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Paula Lauria
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Abelardo Neto
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Anna Luiza Paola Martins
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Livia Lucas Lima
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Celso Ungier
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Sandra Bastos
,
Allergy and Immunology, Instituto Nacional De Saude Da Mulher, Da Criança e Do Adolescente Fernandes Figueira - IFF/ Fiocruz, Rio de Janeiro, Brazil
Background: Severe combined immunodeficiency (SCID) is the most serious form of a group of diseases characterized by an abnormality in the development and / or function of T cells and may be associated with defects in B cells and Natural Killer cells.
Methods: Case report of a 2 years old male diagnosed with Severe Combined Immunodeficiency (SCID) at 5 months of age investigated to define the molecular basis of the disease due the untimely death of two siblings.
Results: the mutation detected was a defect of the common gamma chain of the interleukin 2 receptor (IL2RƳ). Even though genetic counseling advised otherwise the patient's mother got pregnant during follow-up and as no compatible donor was found we chose to wait birth and verify compatibility. Genetic evaluation of the newborn revealed the absence of the IL2Rγ gene defect in blood cord and a matching HLA. Cord stem cell transplantation was scheduled afterwards.
Conclusions: the patient's mutation is the most common variant (IL2Rγ gene defect) in the X-linked expressed pattern of the XL T-B+NK-phenotype which corresponds to about 45% of severe combined immunodeficiency according to the literature.
